Drugs Containing Excipient (Inactive Ingredient) ETHYL ACETATE

Branded drugs containing ETHYL ACETATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Bausch Health US LLC	PENLAC	ciclopirox	0187-5180	ETHYL ACETATE
SpecGx LLC	RESTORIL	temazepam	0406-9915	ETHYL ACETATE
Mayne Pharma LLC	IMVEXXY	estradiol	50261-104	ETHYL ACETATE
Mayne Pharma LLC	BIJUVA	estradiol and progesterone	50261-211	ETHYL ACETATE
Mayne Pharma	IMVEXXY	estradiol	68308-747	ETHYL ACETATE
Mayne Pharma	BIJUVA	estradiol and progesterone	68308-751	ETHYL ACETATE

Generic drugs containing ETHYL ACETATE excipient

Company	Ingredient	NDC	Excipient
Hikma Pharmaceuticals USA Inc	icosapent ethyl	0054-0508	ETHYL ACETATE
Bausch Health US LLC	ciclopirox	0187-5180	ETHYL ACETATE
SpecGx LLC	temazepam	0406-9915	ETHYL ACETATE
Teva Pharmaceuticals Inc	icosapent ethyl	0480-0126	ETHYL ACETATE
Cosette Pharmaceuticals Inc	ciclopirox	0713-0317	ETHYL ACETATE
Rebel Distributors Corp	ciclopirox	21695-475	ETHYL ACETATE

Market Dynamics and Financial Trajectory for Ethyl Acetate in the Pharmaceutical Excipients Sector

Last updated: February 20, 2026

What is the market size and growth projection for Ethyl Acetate as a pharmaceutical excipient?

The global demand for Ethyl Acetate in pharmaceutical excipients was valued at approximately USD 250 million in 2022. Projected compound annual growth rate (CAGR) for the sector from 2023 to 2030 is approximately 5.2%. The growth is driven by increased demand for solvent-based processes in drug formulation and the development of oral and topical delivery systems.

Which factors influence the demand for Ethyl Acetate in pharmaceuticals?

Increasing pharmaceutical production

Global pharmaceutical sales reached USD 1.3 trillion in 2022, with a sustained annual growth of about 6%. Ethyl Acetate acts as a solvent in drug manufacturing, clean-label formulations, and coating processes, thereby aligning with industry growth.

Regulatory environment

Regulations such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) favor the use of food-grade and pharmaceutical-grade Ethyl Acetate for specific applications, reinforcing market stability.

Consumer preference

Rising preference for natural and solvent-free formulations encourages the adoption of solvent-based excipients like Ethyl Acetate in controlled environments.

How does market competition shape the Ethyl Acetate sector?

Major producers

Leading manufacturers with integrated supply chains include Eastman Chemical, Merck KGaA, and Jiangsu Sopo (China). Market share distribution as of 2022 is roughly 35% for Eastman, 25% combined for the European players, and smaller shares for regional producers.

Pricing dynamics

Prices for pharmaceutical-grade Ethyl Acetate have remained stable, averaging USD 2 per kilogram in 2022, with minor fluctuations due to raw material costs such as acetic acid and ethanol.

Supply chain considerations

The availability of ethanol and acetic acid influences Ethyl Acetate prices. Disruptions in ethanol supply have caused temporary price hikes of up to 10% in 2021.

What are the major trends influencing the financial outlook?

Shift to sustainable production methods

Manufacturers are investing in eco-friendly processes that reduce volatile organic compound (VOC) emissions, leading to higher capital expenditures but more sustainable margins long-term.

Innovation in application areas

Development of Ethyl Acetate formulations for biodegradability and controlled release systems opens additional revenue streams, with R&D investments increasing at an estimated 8% annually.

Geographical diversification

Emerging markets such as India and Southeast Asia are expanding their capacity to serve local pharmaceutical industries, reducing dependence on Western suppliers and potentially initiating price competition.

What are the financial risks and opportunities?

Risks

• Regulation tightening concerning solvent residues may restrict certain applications, decreasing demand.
• Raw material price volatility, particularly ethanol and acetic acid, could raise manufacturing costs.

Opportunities

• Growth in biosimilar and peptide drugs, which utilize Ethyl Acetate as a solvent or excipient.
• Increased adoption in oral drug coatings due to compatibility with film-forming polymers.

Summary table: Key financial metrics (2022–2030 projections)

Metric	2022 Value	2023–2030 CAGR	2030 Projection
Market Size (USD million)	250	5.2%	~370
Price per kilogram (USD)	2	Stability / slight increase	2.2–2.5
Raw material costs increase	N/A	4% annually	N/A
R&D investment growth	N/A	8% annually	N/A

Key takeaways

• Ethyl Acetate's role as a solvent in pharmaceutical production sustains stable growth.
• Industry trends favor sustainable and innovative formulations, which could drive higher profit margins.
• Raw material costs and regulatory changes pose potential risks but can be mitigated through diversification and technological advancements.
• The expanding presence of regional manufacturers increases competitive pressure but also opens local market opportunities.

FAQs

What are the primary applications of Ethyl Acetate in pharmaceuticals?

It acts mainly as a solvent in drug synthesis, excipient for coating, and in the film-forming process for controlled release formulations.

How does Ethyl Acetate's environmental impact influence market prospects?

Lower VOC emissions and the trend toward greener manufacturing have prompted investments in sustainable production processes, making Ethyl Acetate more appealing in regulatory and consumer contexts.

Are there any quality standards specific to pharmaceutical-grade Ethyl Acetate?

Yes. It must meet standards such as USP, EP, and JP specifications, including purity levels above 99.5%, limited residual solvents, and compliance with Good Manufacturing Practice (GMP).

How are raw material prices affecting Ethyl Acetate production costs?

Fluctuations in ethanol and acetic acid prices directly impact Ethyl Acetate costs. Ethanol price swings of up to 10% in recent years have translated into similar shifts in manufacturing expenses.

What are the geographic regions with the highest growth potential?

Emerging markets like India, China, and Southeast Asia are expanding their pharmaceutical manufacturing base, increasing demand for locally produced Ethyl Acetate.

---

References

[1] Grand View Research. (2023). Ethyl Acetate Market Size, Share & Trends Analysis Report.
[2] MarketsandMarkets. (2022). Pharmaceutical Excipients Market by Type, Application, and Region.